Case Western Reserve University's Technology Transfer Office (TTO) serves our innovators with full-spectrum intellectual property services. For both faculty and students, we provide support for intellectual property and commercialization that spans the research & development continuum. We serve our researchers by assessing and building upon the commercial potential of new ideas and inventions.
Through interaction with our inventors, regional and national networks, including our affiliate healthcare systems, and potential commercial partners, we endeavor to determine the best path of translation and ultimate commercialization for University intellectual assets.
Consistent with the University's mission, the Technology Transfer Office is working towards enhancing its role in the promotion of an inclusive culture of global citizenship by exploring issues of access to essential medicines by resource-limited countries. This work includes moving towards the Universities Allied for Essential Medicine's Global Access Licensing Framework.
Lucid Diagnostics and Collaborators Present New EsoGuard® and EsoCheck® Data at Digestive Disease Week® (DDW) 2023 Conference
--PAVmed, May 11, 2023
Biomarkers and Balloons Help in the Fight Against Esophageal Cancer
--AUTM, April 21, 2023
Lucid Diagnostics Reports Publication of Future Effective Foundational Local Coverage Determination by Medicare Administrative Contractor Noridian Healthcare Solutions
-PAVmed, April 18, 2023
NervGen Pharma Presenting Phase 1b/2a Study Design at American Spinal Injury Association 50th Annual Scientific Meeting
--NervGen, April 13, 2023
Please visit our TTO News webpage for more articles and press releases about TTO success stories.
For Questions About...
- Your Invention Disclosure Form (IDF), please contact Joy Chen at 216.368.0362.
- A Material Transfer Agreement (MTA) please contact Tyler Gray at 216.368.1401.
- A Data Use Agreement (DUA), please contact email@example.com.
- Anything else, please contact Daniel Pendergast at 216.368.0184.